New Data from Guadalajara Illuminate Research in Thrombocytopenia (Evaluation of the Effects of Atorvastatin and N-Acetyl Cysteine on Platelet Counts in Patients with Primary Immune Thrombocytopenia: An Exploratory Clinical Trial).

Předmět:	IDIOPATHIC thrombocytopenic purpura ACETYLCYSTEINE PLATELET count CLINICAL trials THROMBOCYTOPENIA
Zdroj:	Clinical Trials Week; 6/26/2023, p159-159, 1p
Abstrakt:	Keywords: Amino Acids; Angiology; Antihyperlipidemic Agents; Atorvastatin Therapy; Blood Platelet Disorders; Clinical Research; Clinical Trials and Studies; Cysteine; Drugs and Therapies; Health and Medicine; Hematologic Diseases and Conditions; Hematology; Neutral Amino Acids; Pharmaceuticals; Sulfhydryl Compounds; Sulfur Amino Acids; Thrombocytopenia EN Amino Acids Angiology Antihyperlipidemic Agents Atorvastatin Therapy Blood Platelet Disorders Clinical Research Clinical Trials and Studies Cysteine Drugs and Therapies Health and Medicine Hematologic Diseases and Conditions Hematology Neutral Amino Acids Pharmaceuticals Sulfhydryl Compounds Sulfur Amino Acids Thrombocytopenia 159 159 1 06/26/23 20230626 NES 230626 2023 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on thrombocytopenia are presented in a new report. Of the responder group, five patients maintained a complete response after treatment (55.5%), three patients maintained a partial response (33.3%), and one patient (11.1%) lost their response to the treatment. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu